BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1381509)

  • 1. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.
    Karpas A; Lowdell M; Jacobson SK; Hill F
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8351-5. PubMed ID: 1381509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
    Duncan JI
    J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection.
    Thomson AW; Bonham CA
    Adv Exp Med Biol; 1995; 374():211-6. PubMed ID: 7572394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
    Rosenwirth B; Billich A; Datema R; Donatsch P; Hammerschmid F; Harrison R; Hiestand P; Jaksche H; Mayer P; Peichl P
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1763-72. PubMed ID: 7527198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus.
    Borvak J; Chou CS; Van Dyke G; Rosenwirth B; Vitetta ES; Ramilo O
    J Infect Dis; 1996 Oct; 174(4):850-3. PubMed ID: 8843228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1.
    Briggs CJ; Ott DE; Coren LV; Oroszlan S; Tözsér J
    Arch Virol; 1999; 144(11):2151-60. PubMed ID: 10603169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus.
    Mortola E; Endo Y; Ohno K; Watari T; Tsujimoto H; Hasegawa A
    Vet Res Commun; 1998 Dec; 22(8):553-63. PubMed ID: 10066129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin.
    Altmeyer A; Staruch MJ; Fischer PA; Durette PL; Tocci MJ; Sigal NH; Dumont FJ
    Int J Immunopharmacol; 1991; 13(8):1187-99. PubMed ID: 1726093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
    Fruman DA; Klee CB; Bierer BE; Burakoff SJ
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3686-90. PubMed ID: 1373887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
    Galvin F; Freeman GJ; Razi-Wolf Z; Benacerraf B; Nadler L; Reiser H
    Eur J Immunol; 1993 Jan; 23(1):283-6. PubMed ID: 7678228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A and FK-506 inhibit development of superantigen-potentiated collagen-induced arthritis in mice.
    Takaoka Y; Nagai H; Tanahashi M; Kawada K
    Gen Pharmacol; 1998 May; 30(5):777-82. PubMed ID: 9559334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function.
    Holländer GA; Bierer BE; Burakoff SJ
    Transfus Sci; 1994 Sep; 15(3):207-20. PubMed ID: 10155542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines.
    Pani A; Marongiu ME; La Colla P
    Antiviral Res; 1993 Sep; 22(1):31-43. PubMed ID: 8250542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production.
    Attur MG; Patel R; Thakker G; Vyas P; Levartovsky D; Patel P; Naqvi S; Raza R; Patel K; Abramson D; Bruno G; Abramson SB; Amin AR
    Inflamm Res; 2000 Jan; 49(1):20-6. PubMed ID: 10778917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.
    Mlynar E; Bevec D; Billich A; Rosenwirth B; Steinkasserer A
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice.
    Nagai H; Hiyama H; Matsuo A; Ueda Y; Inagaki N; Kawada K
    J Pharmacol Exp Ther; 1997 Oct; 283(1):321-7. PubMed ID: 9336339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages.
    Strestíková P; Otová B; Filipec M; Farghali H
    Physiol Res; 2000; 49(6):725-8. PubMed ID: 11252540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of FK-506 and cyclosporin A on the proliferation of PHA-stimulated T cells in response to IL-2, IL-4 or IL-6.
    Liu J; Sakane T; Tsunematsu T
    Int Arch Allergy Immunol; 1992; 98(4):293-8. PubMed ID: 1384862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes.
    Moutabarrik A; Nakanishi I; Takahara S; Hachim K; Bengahnem MG; Ramadani B; Ishibashi M; Zaid D
    Transpl Int; 1994; 7 Suppl 1():S552-5. PubMed ID: 11271305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.